Zoledronic Acid 5 mg/Bag 100 ml Inj

DRUG2 trials

Sponsors

University of Nebraska, Hadassah Medical Organization

Conditions

Bariatric Surgery CandidateBone LossBone ResorptionHIV Infected IndividualsOsteopenia

Phase 1

Healthy Body, Healthy Bones After Bariatric Surgery Trial

CompletedNCT04279392

University of NebraskaBariatric Surgery Candidate, Bone Loss, Bone Resorption

Start: 2020-09-01End: 2022-12-30Updated: 2024-09-24

Phase 4

Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals

RecruitingNCT06762730

Hadassah Medical OrganizationHIV Infected Individuals, Osteopenia

Start: 2024-12-09End: 2032-12-01Target: 110Updated: 2025-09-18

Related Papers

Protocol for a pilot randomised controlled trial of zoledronic acid to prevent bone loss following sleeve gastrectomy surgery

BMJ Open2021-12-011 citations